GlycoBio's new Southeast Asia VP will oversee bio-isoprene project

ERJ staff report (LMH)

Houston, Texas - Glycos Biotecnologies, an international biochemical company, has appointed Rashmi Shah as vice president of GlycosBio's subsidiary in Southeast Asia.

GlycosBio, which commercialises biological processes that convert low-value feedstocks into high-value sustainable chemicals, said that Shah will support the construction and commission of the company's biochemical plant, and biotechnology research and development facility in Malaysia. The unit will produce isoprene monomer.

Construction of the plant in Bio-XCell, a dedicated biotechnology park in Johor, Malaysia, will begin in the third quarter of 2011, with an expected completion date in Q4 2014.

“Rashmi's unique background and extensive experience in building and managing advanced petrochemical facilities in the US and abroad will make him a tremendous asset to the GlycoBio's management team. We are excited to have Rashmi join us in supporting the company's expansion in Malaysia,” said Richard Cilento Jr, CEO of GlycosBio.

An oil and gas expert, including significant time leading expansion projects within Southeast Asia, Shah brings extensive experience handling startup planning and execution, multinational staff development, management and process design and development.

“Leading the commissioning of an advanced biochemical facility allows me to utilise my diverse international expertise and build upon my petrochemical and engineering background. I look forward to supporting GlycosBio's commercialisation efforts in producing isoprene to support Malaysia's rubber industry and meeting the growing global demand for clean, environmentally safe biochemicals,” said Shah.

This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.

Press release from Glycos Biotechnologies